Hyperbaric Treatment Shows Significant Clinical Improvements for Autism
|
By HospiMedica International staff writers Posted on 24 Mar 2009 |

Image: Autistic children receiving hyperbaric treatment (Photo courtesy of Bruce McKeeman).
A new study reports that hyperbaric treatment--inhaling up to 100% oxygen at a pressure greater than one atmosphere in a pressurized chamber--for children with autism has led to improvements in the condition.
Researchers at the International Child Development Resource Center (ICDRC, Melbourne, FL, USA), the Center for Autism Research and Education (Phoenix, AZ, USA), and four other centers in the United States conducted a randomized, controlled, double-blind trial that studied 62 children with autism, aged 2-7 years, to assess the efficacy of hyperbaric treatment. The children were randomly assigned to either 40 hours of hyperbaric treatment at 1.3 atmospheres and 24% oxygen (treatment group) or slightly pressurized room air at 1.03 atmospheres and 21% oxygen (non-treatment group). Clinical outcomes were evaluated by three different scales: the Clinical Global Impression (CGI) scale, the Aberrant Behavior Checklist (ABC), and the Autism Treatment Evaluation Checklist (ATEC).
The researchers found that after 40 sessions, mean physician CGI scores significantly improved in the treatment group compared to controls in overall functioning, receptive language, social interaction, and eye contact; nine out of 30 children (30%) in the treatment group were rated as "very much improved" or "much improved", compared to two of 26 (8%) of controls; 24 out of 30 children (80%) in the treatment group improved compared to 10 out of 26 of controls. Mean parental CGI scores significantly improved in the treatment group compared to controls in overall functioning, receptive language, and eye contact.
The researchers also found that children with autism in the treatment group had significant improvements in overall functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness compared to children in the non-treatment group. On the ABC, significant improvements were observed in the treatment group in total score, irritability, stereotypy, hyperactivity, and speech, but not in the control group. In the treatment group compared to the control group, mean changes on the ABC total score and subscales were similar except a greater number of children improved in irritability. On the ATEC, sensory/cognitive awareness significantly improved in the treatment group compared to the control group. Post-hoc analysis indicated that children over age 5 and children with lower initial autism severity had the most robust improvements. The hyperbaric treatment itself was safe and well tolerated. The study was published on March 13, 2009 in the open access journal, BMC Pediatrics, a publication of BioMed Central.
"Given the positive findings of this study, and the shortage of proven treatments for individuals with autism, parents who pursue hyperbaric treatment for their child with autism can be assured that it is a safe treatment modality at the pressure used in this study, and that it may improve certain autistic behaviors," concluded lead author Dan Rossignol, M.D., and colleagues.
Related Links:
International Child Development Resource Center
Center for Autism Research and Education
Researchers at the International Child Development Resource Center (ICDRC, Melbourne, FL, USA), the Center for Autism Research and Education (Phoenix, AZ, USA), and four other centers in the United States conducted a randomized, controlled, double-blind trial that studied 62 children with autism, aged 2-7 years, to assess the efficacy of hyperbaric treatment. The children were randomly assigned to either 40 hours of hyperbaric treatment at 1.3 atmospheres and 24% oxygen (treatment group) or slightly pressurized room air at 1.03 atmospheres and 21% oxygen (non-treatment group). Clinical outcomes were evaluated by three different scales: the Clinical Global Impression (CGI) scale, the Aberrant Behavior Checklist (ABC), and the Autism Treatment Evaluation Checklist (ATEC).
The researchers found that after 40 sessions, mean physician CGI scores significantly improved in the treatment group compared to controls in overall functioning, receptive language, social interaction, and eye contact; nine out of 30 children (30%) in the treatment group were rated as "very much improved" or "much improved", compared to two of 26 (8%) of controls; 24 out of 30 children (80%) in the treatment group improved compared to 10 out of 26 of controls. Mean parental CGI scores significantly improved in the treatment group compared to controls in overall functioning, receptive language, and eye contact.
The researchers also found that children with autism in the treatment group had significant improvements in overall functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness compared to children in the non-treatment group. On the ABC, significant improvements were observed in the treatment group in total score, irritability, stereotypy, hyperactivity, and speech, but not in the control group. In the treatment group compared to the control group, mean changes on the ABC total score and subscales were similar except a greater number of children improved in irritability. On the ATEC, sensory/cognitive awareness significantly improved in the treatment group compared to the control group. Post-hoc analysis indicated that children over age 5 and children with lower initial autism severity had the most robust improvements. The hyperbaric treatment itself was safe and well tolerated. The study was published on March 13, 2009 in the open access journal, BMC Pediatrics, a publication of BioMed Central.
"Given the positive findings of this study, and the shortage of proven treatments for individuals with autism, parents who pursue hyperbaric treatment for their child with autism can be assured that it is a safe treatment modality at the pressure used in this study, and that it may improve certain autistic behaviors," concluded lead author Dan Rossignol, M.D., and colleagues.
Related Links:
International Child Development Resource Center
Center for Autism Research and Education
Latest Critical Care News
- Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreSurgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







